IP Library › Granted Patent US 12,564,686
Granted Patent B2
US 12,564,686 · App. 18/745,151 · Granted Mar 3, 2026

RFID tag enabled shield assembly

Inventors: Markus Bauss (Lengdorf, DE); Thomas Dietl (Farkenfels, DE)
Assignee: SHL Medical AG
A61M5/3202A61M5/31A61M5/3213A61M2205/6054
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,564,686
App. No.
18/745,151
Granted
Mar 3, 2026
Kind
B2
Abstract

The present invention relates to an RDID tag enabled shield assembly that provides a sterile enclosure of a medicament delivery port of a medicament container. The container can be a needleless pre-filled syringe, a vial, a cartridge, or a collapsible bag or pouch. The RFID tag is fixedly attached to one or more components of the shield assembly through co-molding or another form of permanent or removable attachment. The present invention also relates to a method of tracking the life cycle of a medicament container or a medicament injection device where the RFID tag enabled shield assembly attached to the medicament container. Data is written to or read from the RFID tag during the entire life cycle of the medicament container or injection device, including assembly, packaging, storing, distribution and use.

Claims (23)

1 . A shield assembly configured to be removably attached to a medicament container of a medicament delivery device and covering a medicament delivery port, the shield assembly comprising:

a flexible component removably coupled to the medicament delivery port, forming a sterile and liquid seal with the medicament delivery port;

a less flexible component securely attached to the flexible component such that axial movement of the less flexible component relative to the medicament container causes simultaneous axial movement of the flexible component that unseals the medicament delivery port; and

an RFID tag fixedly attached to the less flexible component, where the RFID tag contains readable data comprising date of manufacture, lot number, medicament filling, shipping, or warehousing information directly related the manufacture of the medicament container,

wherein the RFID tag contains the data before the medicament container is incorporated into the medicament delivery device, and

wherein the less flexible component includes a cavity that fixedly retains the RFID tag and a support pillar that is positioned adjacent to the RFID tag to prevent bending or cracking of the RFID tag.

2 . The shield assembly of claim 1 , wherein the medicament container is a pre-filled syringe and the medicament delivery port is an injection needle.

3 . The shield assembly of claim 1 further comprising a cap with an attached grabber, where the grabber is axially fixed to an inside portion of the cap.

4 . The shield assembly of claim 3 , wherein the grabber surrounds the less flexible component and comprises a plurality of pointed tongues that engage the shield assembly when the cap is proximally moved axially relative to the medicament delivery device.

5 . The shield assembly of claim 1 , wherein the RFID tag is a read-write tag.

6 . The shield assembly of claim 1 , wherein the RFID tag comprises a read-only memory.

7 . The shield assembly of claim 1 , wherein the RFID tag is fixedly attached by one of a snap fit, an inlay, co-molded, an adhesive, lamination, taped, a press fit or a combination thereof.

8 . The shield assembly of claim 1 , wherein the RFID is attached to a proximal end of the less flexible component.

9 . The shield assembly of claim 1 , further comprising:

an antenna in electrical communication with the RFID tag.

10 . The shield assembly of claim 9 , wherein the antenna in directly attached to the less flexible component.

11 . The shield assembly of claim 1 , wherein the shield assembly is releasably connected to a collapsible medicament container.

12 . The shield assembly of claim 1 , wherein the cavity comprises snap features having one or more flexible fingers that engage the RFID tag.

13 . The shield assembly of claim 1 , wherein the cavity is integral to an inside surface of the less flexible component such that when the flexible component and the RFID tag are inserted into the less flexible component the RFID tag is forced into the cavity.

14 . The shield assembly of claim 1 , further comprising:

an accessory removably connected to an outside surface of the medicament delivery device and configured to acquire information directly from the RFID tag.

15 . The shield assembly of claim 14 , wherein the accessory communicates wirelessly with an external source to track the functioning of the device and to transmit the information acquired from the RFID tag.

16 . A medicament delivery device including the shield assembly of claim 1 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2024
From: BAUSS, MARKUS
To: SHL MEDICAL AG
Reel/Frame 067825/0424 →
Priority Claims (1)
EP 16178833 · Jul 11, 2016 · regional
Continuity (4)
Continuation 18144948 · May 9, 2023
Continuation In Part 16361576 · Mar 22, 2019
Continuation In Part 16311545
Related Publication 20240335619A1 · Oct 10, 2024
References Cited (43)
US 5554127A · Crouther et al. · 1996 [cited by applicant]
US 7141286B1 · Kessler et al. · 2006 [cited by applicant]
US 20070239112A1 · Fago et al. · 2007 [cited by applicant]
US 20080191013A1 · Liberatore · 2008 [cited by applicant]
US 20080221549A1 · Cohen · 2008 [cited by examiner]
US 20090043253A1 · Podaima · 2009 [cited by applicant]
US 20090306620A1 · Thilly · 2009 [cited by examiner]
US 20120103140A1 · Kessler et al. · 2012 [cited by applicant]
US 20130072879A1 · Avery et al. · 2013 [cited by applicant]
US 20130172819A1 · Iio · 2013 [cited by applicant]
US 20140223862A1 · Nicoletti et al. · 2014 [cited by applicant]
US 20140276213A1 · Bochenko · 2014 [cited by applicant]
US 20140336588A1 · McLoughlin et al. · 2014 [cited by applicant]
US 20150080810A1 · Henderson et al. · 2015 [cited by applicant]
US 20150217059A1 · Ashby et al. · 2015 [cited by applicant]
US 20150314077A1 · Karlsson et al. · 2015 [cited by applicant]
US 20160022539A1 · Daines · 2016 [cited by applicant]
US 20160089530A1 · Sathe · 2016 [cited by applicant]
US 20160144132A1 · Scanlon · 2016 [cited by applicant]
US 20180104413A1 · Mcloughlin · 2018 [cited by examiner]
CN 101304775A · 2008 [cited by applicant]
CN 100553582C · 2009 [cited by applicant]
CN 102847209A · 2013 [cited by applicant]
CN 102968724A · 2013 [cited by applicant]
CN 202854125U · 2013 [cited by applicant]
CN 103608055A · 2014 [cited by applicant]
CN 104010678A · 2014 [cited by applicant]
CN 203874219U · 2014 [cited by applicant]
CN 104379195A · 2015 [cited by applicant]
CN 105530980A · 2016 [cited by applicant]
JP 2008535569A · 2008 [cited by applicant]
JP 2010540054A · 2010 [cited by applicant]
JP 2014514120A · 2014 [cited by applicant]
JP 2015514524A · 2015 [cited by applicant]
TW 201509474A · 2015 [cited by applicant]
WO 2005051285A1 · 2005 [cited by applicant]
WO 2006108026A2 · 2006 [cited by applicant]
WO 2009040601A1 · 2009 [cited by applicant]
WO 2012152628A1 · 2012 [cited by applicant]
WO 2012164390A2 · 2012 [cited by applicant]
WO 2013160152A1 · 2013 [cited by applicant]
WO 2014075685A2 · 2014 [cited by applicant]
WO 2015110533A2 · 2015 [cited by applicant]